Posts by Admin BioAlps
Oculis raises CHF20 million and moves to Switzerland
Oculis, a clinical-stage biotechnology company focused on the development of non-invasive topical treatment for back-of-the-eye diseases, announced it has successfully closed a Series B financing round of CHF 20 million. In conjunction with the financing, Oculis is re-locating its corporate headquarters to Lausanne. Full startupticker.ch article
Read More14ème édition du Prix à l’innovation du canton de Fribourg
Fribourg recherche les entreprises et les start-up les plus innovantes Toutes les entreprises établies dans le canton de Fribourg peuvent participer au Prix à l’innovation, dans la catégorie «Entreprise» si la société a été créée avant 2013, et dans la catégorie «Start-up» si la société a été créée dès 2013. Le vainqueur du Prix Entreprise remporte 10’000…
Read MoreSwiss BioInformatics Institute celebrates its 20th anniversary
BIOINFORMATICS, A SWISS PRIDE – 20 YEARS OF SERVICE TO THE LIFE SCIENCES AND HEALTH As a pioneer in the field, Switzerland is recognized for its know-how and expertise. The SIB Swiss Institute of Bioinformatics was formed on 30 March 1998 thanks to the support from the Confederation, which recognized the promising future of this…
Read MoreLife Sciences Innovation Hotspot
Succeeding in Swiss and European R&D Projects 26 April 2016, 08:30–14:00 in Geneva Campus Biotech Grand auditoire (bât. H8) 9, ch. des Mines For registration and more information
Read MoreEspeRare gains rights to relaunch late stage development for a rare genetic disease
EspeRare is delighted to announce that it has concluded an important agreement with Edimer Pharmaceuticals. Lire le communiqué de presse Read the press release
Read MoreRetraites Populaires and Biopôle SA launch the first life sciences incubator in Canton of Vaud
9,100 m2 building, funded and constructed by Retraites Populaires on the site of Biopôle, a leading Swiss life science park. “24 Heures” article – in French “Agefi” article – in French Read the full press release – in English
Read MoreBioFoundry – Open Insulin Project – Call for Partnering Proposals
The Open Insulin mouvement was started in California with the intention of bringing the price of insulin down. The project’s current goal is to bring new generic manufacturers into the industry, by lowering the cost/technical barriers to entry. For the most part, this is a problem created as each manufacturer is required to get the…
Read MoreSimplicityBio – Sales Manager position now open
The Swiss based company, founded in 2015, active in the discovery of novel medical biomarkers by means of patented bioinformatics machine-learning platform BOSS, is looking for a Sales Manager. Job description and details
Read MoreMedTech Investing Europe 2018 (MTi)
The 26th MedTech Investing Europe Conference will be held on 24 and 25 April 2018 at the Royal Savoy Hotel in Lausanne, Switzerland. The MedTech Investing Europe Conference offers a perfect combination of the latest investment opportunities in game-changing technologies and unrivalled programme content giving first-hand insight and opinion from senior-level MedTech experts. The MTi…
Read MoreAnergis and Mymetics Start Research Collaboration Project
Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines, and Anergis SA, a company developing Contiguous Overlapping Peptides (COPs) for ultra-fast allergy immunotherapy, announced that Mymetics SA, the Swiss subsidiary of Mymetics Corporation and Anergis SA have entered into a Research Collaboration project. The pre-clinical study program will evaluate…
Read More